IRIS
BARRECA, Maria Letizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.245
EU - Europa 3.283
AS - Asia 1.658
SA - Sud America 497
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 12.730
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.171
RU - Federazione Russa 1.684
SG - Singapore 671
CN - Cina 491
BR - Brasile 436
IE - Irlanda 374
SE - Svezia 329
UA - Ucraina 284
HK - Hong Kong 178
DE - Germania 173
VN - Vietnam 162
GB - Regno Unito 130
FI - Finlandia 82
FR - Francia 74
IT - Italia 52
CA - Canada 41
IN - India 40
AR - Argentina 26
MX - Messico 22
CZ - Repubblica Ceca 18
PL - Polonia 16
IQ - Iraq 15
TR - Turchia 15
BD - Bangladesh 14
BE - Belgio 14
NL - Olanda 11
ZA - Sudafrica 11
EC - Ecuador 10
PK - Pakistan 10
UZ - Uzbekistan 10
TN - Tunisia 8
VE - Venezuela 8
ES - Italia 7
EG - Egitto 6
IR - Iran 6
JP - Giappone 6
CI - Costa d'Avorio 5
CO - Colombia 5
ID - Indonesia 5
IL - Israele 5
MA - Marocco 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
HN - Honduras 4
LT - Lituania 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
GR - Grecia 3
GT - Guatemala 3
KE - Kenya 3
PE - Perù 3
CY - Cipro 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
SV - El Salvador 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 12.730
Salva come PNG Salva come JPEG
Città #
Dallas 4.544
Moscow 496
Jacksonville 488
Singapore 392
Dublin 374
Chandler 364
Ashburn 287
Nyköping 224
Hong Kong 178
Beijing 174
Dong Ket 115
San Jose 97
Los Angeles 89
The Dalles 77
Princeton 75
Cambridge 73
Medford 71
Lauterbourg 61
Des Moines 58
Boardman 50
Dearborn 41
Buffalo 38
Council Bluffs 30
Lancaster 28
São Paulo 28
Ann Arbor 27
Woodbridge 27
Tianjin 23
Guangzhou 19
Wilmington 19
Brno 18
Nanjing 18
Chicago 16
Jinan 16
Rio de Janeiro 16
Belo Horizonte 15
Haikou 15
Ho Chi Minh City 15
Brussels 14
Munich 14
New York 14
Ottawa 14
London 13
Warsaw 13
Brooklyn 12
Hebei 12
Hyderabad 12
Orem 12
Hanoi 11
Shenyang 11
Taizhou 11
Washington 11
Saint Petersburg 10
Santa Clara 10
Seattle 10
Amsterdam 9
Frankfurt am Main 9
Pune 9
San Mateo 9
Tashkent 9
Zhengzhou 9
Manchester 8
Milan 8
Montreal 8
Atlanta 7
Brasília 7
Campinas 7
Curitiba 7
Denver 7
Hangzhou 7
Norwalk 7
Phoenix 7
Poplar 7
San Francisco 7
Santo André 7
Stockholm 7
Auburn Hills 6
Baghdad 6
Istanbul 6
Johannesburg 6
Leawood 6
Tokyo 6
Toronto 6
Tunis 6
Abidjan 5
Ardabil 5
Campo Grande 5
Dhaka 5
Fuzhou 5
Lahore 5
Mexico City 5
Redondo Beach 5
Riva 5
Shanghai 5
Shenzhen 5
Taiyuan 5
Boston 4
Córdoba 4
Diadema 4
Divinópolis 4
Totale 9.186
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.607
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 278
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 244
Anti-HIV agents: design and discovery of new potent RT inhibitors 169
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 166
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 164
A comprehensive structural overview of p38α MAPK in complex with type I inhibitors 154
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 153
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 151
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 149
Binding modes of noncompetitive AMPA antagonists: a computational approach 147
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 144
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 143
3-D QSAR MODELS AND DOCKING STUDIES OF REVERSIBLE INHIBITORS OF TYPE A AND B MONOAMINE OXIDASE 143
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 136
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 136
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 134
Efficient 3D Database screening for novel HIV-1 IN inhibitors 134
Computational studies of inhibitor resistance in HIV-1 integrase 134
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 133
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 129
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 128
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 125
Synthesis of new potential HIV-1 integrase inhibitors 122
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 116
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 112
Design and Synthesis of NR2B Subtype-Selective Antagonist 108
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 107
Molecular modeling e disign di inibitori dell'integrasi dell'HIV-1 107
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 107
Design and synthesis of new HIV-1 NNRTIs 105
Dynamic pharmacophore model development and testing 104
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 104
MD STUDIES OF THE WILD TYPE AND MUTANT HIV-1 INTEGRASE COMPLEXED WITH THE 5CITEP INHIBITOR: MECHANISM FOR INHIBITION AND DRUG RESISTANCE 102
DISCOVERY OF HIV-1 INTEGRASE INHIBITORS BY MOLECULAR MODELING STUDIES 100
Search fo non-competitive AMPA antagonists: Synthesis, pharmacological properties and computational studies 100
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 99
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 99
New trends in the development of AMPA receptor antagonists 97
Tetrahydroisoquinoline derivatives: a new class of non-competitive AMPA receptor antagonists with potential anticonvulsant activity 97
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 97
Search for noncompetitive 2-amino-3(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies 96
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones 96
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 95
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 95
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors 95
PROPOSED MECHANISM FOR THE HIV-1 IN INHIBITION AND DRUG RESISTANCE BY MOLECULAR DYNAMICS STUDIES 94
Molecular dynamics studies of the full-length integrase-DNA complex 91
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 90
Noncompetitive AMPA receptor antagonists and proposed pharmacophore model 90
Molecular dynamics studies of the HIV-1 integrase 89
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside riverse transcriptase inhibitors 86
Design e sintesi di nuovi antagonisti noncompetitivi del recettore AMPA 86
Tetrahydroisoquinoline a new class of noncompetitive AMPA receptor antagonists as potential anticonvulsant agents 85
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists 85
Tetrahydroisoquinolin-1-ones as anticonvulsant agents 85
Discovery of novel HIV-1 integrase inhibitors through computational strategies 84
Design e sintesi di nuovi inibitori dell'integrasi dell'HIV-1 84
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 83
Pharmacophore-based design of HIV-1 integrase inhibitors 83
Isoquinoline derivatives as noncompetitive AMPA receptor antagonists 83
DYNAMIC PHARMACOPHORE MODEL DEVELOPMENT AND TESTING 82
NNRTI TBZ-ANALOGHI: PROGETTAZIONE RAZIONALE, SINTESI E SAR 82
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 82
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance 81
Rational design, synthesis and SAR of HIV-1 integrase Inhibitors 80
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist 80
Rational design and synthesis of novel NNRTI TBZ analogues 77
Discovery of a new class of AMPA receptor antagonists containing a tetrahydroisoquinoline skeleton, 75
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS 73
Progettazione di nuovi agenti anti-HIV e individuazione di nuovi lead compound 72
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 63
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 48
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 31
Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors 31
null 28
null 27
null 27
null 25
null 25
null 24
Prion protein ligands as therapeutic agents for neurodegenerative disorders 6
Totale 12.778
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021257 0 0 0 0 0 0 0 0 0 79 48 130
2021/2022457 5 119 3 10 35 0 42 13 8 1 62 159
2022/20231.321 94 90 65 108 108 157 30 99 493 5 65 7
2023/2024339 26 53 17 46 34 68 8 26 1 29 8 23
2024/20251.226 20 35 49 101 14 44 16 289 321 52 84 201
2025/20267.758 131 1.471 3.216 304 269 917 500 417 440 93 0 0
Totale 12.778